|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Net sales | ||||
| Cost of goods sold | ||||
| Gross profit | ||||
| Operating Expenses | ||||
| Administrative fee - related party | ||||
| General and administrative | ||||
| Research and development | ||||
| Selling, general and administrative | ||||
| Total operating expenses | ||||
| Change in fair value of over-allotment liability | ||||
| Operating loss | ||||
| Other Income (Expense) | ||||
| Change in fair value of derivative liabilities | ||||
| Loss on issuance of common stock and warrants | ||||
| Interest income | ||||
| Interest expense | ||||
| Other income (expense) | ||||
| Total other expense | ||||
| Net loss before provision for income taxes | ||||
| Provision for income taxes | ||||
| Net loss | ||||
| Weighted average number of shares of common stock outstanding – basic and diluted (in Shares) | ||||
| Class A Redeemable Common Stock | ||||
| Class A and B Non-Redeemable Common Stock | ||||
| Total weighted average number of shares of common stock outstanding – basic and diluted (in Shares) | ||||
| Weighted average number of shares of common stock outstanding, Diluted (in Shares) | ||||
| Class A Redeemable Common Stock | ||||
| Class A and B Non-Redeemable Common Stock | ||||
| Total weighted average number of shares of common stock outstanding, Diluted (in Shares) | ||||
| Basic and diluted net loss per share of common stock (in Dollars per share) | ||||
| Class A Redeemable Common Stock | ||||
| Class A and B Non-Redeemable Common Stock | ||||
| Total basic and diluted net loss per share of common stock (in Dollars per share) | ||||
| Diluted net loss per share of common stock (in Dollars per share) | ||||
| Class A Redeemable Common Stock | ||||
| Class A and B Non-Redeemable Common Stock | ||||
| Total diluted net loss per share of common stock (in Dollars per share) | ||||
Loading...